Polymorphism of HDAC inhibitor and manufacturing method and applications thereof

TW202631589APending Publication Date: 2026-08-01ANNJI PHARM CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Filing Date
2025-06-30
Publication Date
2026-08-01

Smart Images

  • Figure TWG2TA001070171_001
    Figure TWG2TA001070171_001
  • Figure TWG2TA001070171_002
    Figure TWG2TA001070171_002
  • Figure TWG2TA001070171_003
    Figure TWG2TA001070171_003
Patent Text Reader

Abstract

The present disclosure generally relates to solid state forms of an histone deacetylases (HDACs) inhibitor and pharmaceutical compositions comprising the solid state crystalline forms and pharmaceutically acceptable excipients, and methods for preparing and using the solid state forms and the pharmaceutical compositions thereof.
Need to check novelty before this filing date? Find Prior Art